Hyusiga 10 mg (Dapagliflozin Propanediol Monohydrate)

Adult dose

The recommended dose for this medication, whether used alone or in combination with other hypoglycemic agents such as insulin, is 10 mg once daily. For initial combination therapy with metformin, the recommended starting dose is either 5 mg or 10 mg once daily. This medication can be administered orally once daily at any time, regardless of food intake. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There is no relevant data.

This medication should not be used in patients who are allergic to the active ingredient or additives, as well as in patients with type 1 diabetes, diabetic ketoacidosis, and those on dialysis. It should be used cautiously in patients with restricted fluid volume or impaired kidney function, particularly those with low blood pressure or variables in kidney function requiring regular status assessment. This medication contains color additives Yellow No. 4 and Yellow No. 5, and patients allergic to these components should exercise caution. The most common side effects include genital infections and urinary tract infections. These are generally mild but can recur, so treatment should be sought immediately if symptoms occur. Hypoglycemic symptoms may occur, therefore blood sugar levels should be regularly monitored, especially when used with insulin or other hypoglycemic agents. Dehydration or hypotensive symptoms may occur due to decreased fluid volume, so those at risk of dehydration should be monitored closely, and medication may be temporarily discontinued if necessary. Serious metabolic disturbances like diabetic ketoacidosis can occur rarely; consult healthcare professionals immediately if symptoms like vomiting, abdominal pain, or shortness of breath arise. Patients with severely compromised liver function, elderly individuals, and those on diuretics should be particularly cautious when using this medication and should undergo regular kidney function tests. It is recommended that pregnant or breastfeeding women refrain from using this medication, and if pregnancy is confirmed, the medication should be discontinued immediately. This medication does not significantly affect driving or operating machinery, but caution is advised due to the risk of hypoglycemia. This medication should be stored in its original container, safely out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, difficulty breathing or shortness of breath, asthma attack, cough with accompanying fever and respiratory abnormalities, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, lightning-like headaches, seizures, altered consciousness, visual disturbances, paralysis, urinary

Mild side effects

• Vulvovaginitis
• balanitis and related genital infections
• urinary tract infections
• fungal infection
• hypoglycemia
• thirst
• dizziness
• constipation
• dry mouth
• back pain

This medication can be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. It is advised to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Yellow, double-convex, diamond-shaped, film-coated tablet

Package unit

28 tablets - 7 tablets/PTP[x 4]